|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
Q2 FY2022
As of Jul 31, 2021
|
Q1 FY2022
As of Apr 30, 2021
|
Q4 FY2021
As of Jan 31, 2021
|
Q3 FY2021
As of Oct 31, 2020
|
Q2 FY2021
As of Jul 31, 2020
|
Q1 FY2021
As of Apr 30, 2020
|
Q4 FY2020
As of Jan 31, 2020
|
Q3 FY2020
As of Oct 31, 2019
|
Q2 FY2020
As of Jul 31, 2019
|
Q1 FY2020
As of Apr 30, 2019
|
Q4 FY2019
As of Jan 31, 2019
|
Q3 FY2019
As of Oct 31, 2018
|
Q2 FY2019
As of Jul 31, 2018
|
Q1 FY2019
As of Apr 30, 2018
|
Q4 FY2018
As of Jan 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net of allowances | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Deferred commissions, current portion | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Deferred commissions, net of current portion | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Redeemable Non-Controlling Interests, and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Deferred revenue, current portion | ||||||||||||||||||||
| Current portion of convertible senior notes, net (Note 8) | ||||||||||||||||||||
| Operating lease liabilities, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible senior notes, net (Note 8) | ||||||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies (Note 9) | ||||||||||||||||||||
| Redeemable non-controlling interests (Note 3) | ||||||||||||||||||||
| Other temporary equity (Note 10) | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value per share; 25,000,000 shares authorized at October 31, 2022 and January 31, 2022; zero shares issued and outstanding at October 31, 2022 and January 31, 2022 | ||||||||||||||||||||
| Common stock, $0.0001 par value per share; 625,000,000 shares authorized at October 31, 2022 and January 31, 2022; 76,110,711 and 75,060,139 shares issued and outstanding at October 31, 2022 and January 31, 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities, redeemable non-controlling interests, and stockholders’ equity |
Loading...
